131 related articles for article (PubMed ID: 10942396)
1. Histone deacetylase inhibitors suppress IL-2-mediated gene expression prior to induction of apoptosis.
Koyama Y; Adachi M; Sekiya M; Takekawa M; Imai K
Blood; 2000 Aug; 96(4):1490-5. PubMed ID: 10942396
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
[TBL] [Abstract][Full Text] [Related]
3. The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses.
Moreira JM; Scheipers P; Sørensen P
BMC Cancer; 2003 Nov; 3():30. PubMed ID: 14606959
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 (IL-2) upregulates BAG-1 gene expression through serine-rich region within IL-2 receptor beta c chain.
Adachi M; Sekiya M; Torigoe T; Takayama S; Reed JC; Miyazaki T; Minami Y; Taniguchi T; Imai K
Blood; 1996 Dec; 88(11):4118-23. PubMed ID: 8943845
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment.
Bode KA; Schroder K; Hume DA; Ravasi T; Heeg K; Sweet MJ; Dalpke AH
Immunology; 2007 Dec; 122(4):596-606. PubMed ID: 17635610
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity.
Munshi A; Kurland JF; Nishikawa T; Tanaka T; Hobbs ML; Tucker SL; Ismail S; Stevens C; Meyn RE
Clin Cancer Res; 2005 Jul; 11(13):4912-22. PubMed ID: 16000590
[TBL] [Abstract][Full Text] [Related]
8. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway.
Mayo MW; Denlinger CE; Broad RM; Yeung F; Reilly ET; Shi Y; Jones DR
J Biol Chem; 2003 May; 278(21):18980-9. PubMed ID: 12649266
[TBL] [Abstract][Full Text] [Related]
9. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors.
Zhu WG; Lakshmanan RR; Beal MD; Otterson GA
Cancer Res; 2001 Feb; 61(4):1327-33. PubMed ID: 11245429
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Regulation via Altered Histone Acetylation Results in Suppression of Mast Cell Function and Mast Cell-Mediated Food Allergic Responses.
Krajewski D; Kaczenski E; Rovatti J; Polukort S; Thompson C; Dollard C; Ser-Dolansky J; Schneider SS; Kinney SRM; Mathias CB
Front Immunol; 2018; 9():2414. PubMed ID: 30405614
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
Duan H; Heckman CA; Boxer LM
Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
[TBL] [Abstract][Full Text] [Related]
12. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region.
Han S; Lu J; Zhang Y; Cheng C; Li L; Han L; Huang B
Immunol Lett; 2007 Feb; 108(2):143-50. PubMed ID: 17270283
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
Frønsdal K; Saatcioglu F
Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787
[TBL] [Abstract][Full Text] [Related]
14. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia.
Romanski A; Bacic B; Bug G; Pfeifer H; Gul H; Remiszewski S; Hoelzer D; Atadja P; Ruthardt M; Ottmann OG
Haematologica; 2004 Apr; 89(4):419-26. PubMed ID: 15075075
[TBL] [Abstract][Full Text] [Related]
15. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
Lai JP; Yu C; Moser CD; Aderca I; Han T; Garvey TD; Murphy LM; Garrity-Park MM; Shridhar V; Adjei AA; Roberts LR
Gastroenterology; 2006 Jun; 130(7):2130-44. PubMed ID: 16762634
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells.
Marks PA; Richon VM; Rifkind RA
J Natl Cancer Inst; 2000 Aug; 92(15):1210-6. PubMed ID: 10922406
[TBL] [Abstract][Full Text] [Related]
17. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
Zhang JS; Wang L; Huang H; Nelson M; Smith DI
Genes Chromosomes Cancer; 2001 Feb; 30(2):123-35. PubMed ID: 11135429
[TBL] [Abstract][Full Text] [Related]
18. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors increase p21(WAF1) and induce apoptosis of human myeloma cell lines independent of decreased IL-6 receptor expression.
Lavelle D; Chen YH; Hankewych M; DeSimone J
Am J Hematol; 2001 Nov; 68(3):170-8. PubMed ID: 11754398
[TBL] [Abstract][Full Text] [Related]
20. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
